Rivaroxaban 366789-02-8 Usoro ọbara na-echebe Antithrombosis
Ụgwọ:T/T, L/C
Isi mmalite ngwaahịa:China
Ọdụ ụgbọ mmiri:Beijing/Shanghai/Hangzhou
Ike mmepụta:200kg / ọnwa
Nye iwu (MOQ):25kg
Etiti oge:3 ụbọchị ọrụ
Ọnọdụ nchekwa:Echekwara ya na ebe dị jụụ, ebe akọrọ, okpomọkụ ụlọ.
Ihe ngwugwu:drum
Nha ngwugwu:25kg / agba
Ozi nchekwa:Ọ bụghị ngwongwo dị ize ndụ
Okwu mmalite
Rivaroxaban, bụ ọgwụ anticoagulant (dị mkpa ọbara).Ọ na-eji na ndị okenye nwere fibrillation na-adịghị valvular (ma e wezụga nhụsianya atrial n'ihi ọrịa obi rheumatic valvular, na atrial fibrillation mgbe obi gbanwere valve obi) iji belata ihe ize ndụ nke ọrịa strok na usoro embolism.
A na-eji Rivaroxaban agwọ ma gbochie mkpụkọ ọbara.
Rivaroxaban, a na-eji f maka ndị ọrịa toro eto na-eme nhọrọ ngbanwe hip ma ọ bụ ikpere iji gbochie thrombosis venous.
Nkọwapụta (EP)
| Ihe | Nkọwapụta |
| Ọdịdị | White ma ọ bụ odo ntụ ntụ |
| Solubility | Nke a na-adịghị ahụkebe n'ime mmiri, na-agbaze kpamkpam na DMSO, ihe fọrọ nke nta ka ọ bụrụ ihe a na-apụghị ịsacha na ethanol anhydrous na heptanes. |
| njirimara | IR: Spectrum kwesịrị ịgbaso WS |
| HPLC-RT nke nlele n'okpuru ule ịdị ọcha nke enantiometric kwesịrị ịgbaso nke WS. | |
| Mmiri | ≤0.5% |
| Sulfate ntụ | ≤0.1% |
| Ọnwụ na ihicha | ≤0.5% |
| Ọla dị arọ | ≤20ppm |
| Enantionmer | adịghị ọcha A: ≤0.4% |
| Ihe mgbaze fọdụrụnụ | Ethanol: ≤5000ppm Ethyl acetate: ≤5000ppm Acetone: ≤5000ppm N, N-Dimethylformamide: ≤880ppm Methylene chloride: ≤600ppm Benzene: ≤2pm |
| Ihe metụtara ya | adịghị ọcha B: ≤0.10% adịghị ọcha D: ≤0.10% adịghị ọcha E: ≤0.10% adịghị ọcha F: ≤0.10% adịghị ọcha G: ≤0.10% adịghị ọcha H: ≤0.10% adịghị ọcha I: ≤0.10% adịghị ọcha J: ≤0.10% RVB-4-NJSH: ≤0.10% RVB-ZA: ≤0.10% RVB-BAM: ≤0.10% RVB-ZC: ≤0.10% RVB-HBY: ≤75ppm Ọdịghị ọcha ọ bụla ọzọ amabeghị: ≤0.10% Mkpokọta adịghị ọcha: ≤0.3% |
| Nkesa nha urughuru | D10:/ D50:/ D90:/ |
| Nyocha (ihe anhydrous) | 98.0-102.0 |
